IFIT BCG MATRIX TEMPLATE RESEARCH B_181 Accelerated Product Launch

Accelerated Product Launch

High-margin trio + Sanofi (€210M) fuel FY2025 R&D and FCF with ~72% gross margin

and expert opinions to assess growth

impacting customer trust

Global Market Penetration Expand reach strategically

IFIT BCG MATRIX TEMPLATE RESEARCH B_181 Accelerated Product LaunchActionable Strategy Starts Here iFit's BCG Matrix preview highlights where its connected fitness products likely sit some units showing Star like growth while others risk slipping toward Dog status as competition intensifies. This snapshot flags strategic choices around investment, divestment, and consolidation to sustain subscription revenue and hardware margins. The full BCG Matrix delivers quadrant by quadrant data, actionable recommendations, and